Incannex announces participation at the h.c. wainwright 25th annual global investment conference - september 11-13, 2023

Melbourne, australia, sept. 08, 2023 (globe newswire) -- incannex healthcare limited (nasdaq: ixhl) (asx: ihl), (‘incannex' or the ‘company') a pharmaceutical company developing cannabinoid pharmaceutical medicines and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the h.c. wainwright 25th annual global investment conference - september 11-13, 2023. incannex will be presenting and taking one on one meetings virtually. mr joel latham, ceo and managing director of incannex, will provide an overview of the company's business during the presentation.
IXHL Ratings Summary
IXHL Quant Ranking